Cambridge Investment Research Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Cambridge Investment Research Advisors's ACLS Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Axcelis (ACLS) stake by 33% in Q2 2026, buying an estimated $546K and bringing the position to 14,779 shares worth $2.8M. The position accounts for 0.01% of the portfolio, ranked #1423.
Cambridge Investment Research Advisors first reported a position in ACLS in Q4 2021 and has held it in 18 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Cambridge Investment Research Advisors held 14,779 shares of Axcelis worth $2.8M as of Q2 2026.
- Cambridge Investment Research Advisors bought 3,679 Axcelis shares in Q2 2026, an estimated $546K.
- Axcelis made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1423 holding.
- Cambridge Investment Research Advisors first reported a position in Axcelis in Q4 2021 and has held it in 18 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.